BLOG

Post-Treatment Care for Stem Cell Therapy in Japan

Published 2026.09.17 7 min read

Hello, I am Dr. Hidenori Shimada of Grand Green Osaka Umekita Clinic in Osaka, Japan.

Medical tourism in Japan is attracting global attention, particularly in the field of regenerative medicine. As more international patients consider treatments like adipose-derived stem cell therapy, a common concern arises: “What happens after I return home?” Effective post-treatment care is crucial for monitoring progress and managing long-term health. This article explains the comprehensive follow-up support system Grand Green Osaka Umekita Clinic provides for our international patients, ensuring a continuum of care that bridges geographical distances.

Why is Coordinated Post-Treatment Follow-Up Important?

Stem cell therapy is not a one-time event but the beginning of a process. The period following the treatment is essential for observing your body’s response and ensuring the best possible outcome. Consistent follow-up allows physicians to monitor your condition, manage any changes, and provide guidance. This collaborative approach between you, our clinic in Japan, and your primary physician back home is fundamental to responsible medical care. It helps in assessing the therapeutic course and making informed decisions about your ongoing health management. Without a clear plan for follow-up, patients can feel disconnected and uncertain about their next steps.

Our Support System for International Patients

At Grand Green Osaka Umekita Clinic, we have designed a support system to address the unique needs of international patients. Our goal is to make your post-treatment journey as seamless and reassuring as possible, even after you have returned to your home country. Our support includes several key components:

Medical Reports in English: We provide comprehensive medical summaries detailing the treatment you received. This includes information about the cell collection and culturing process, the administration method, and observations made during your time at our clinic.
Coordination with Your Primary Physician: With your consent, we facilitate communication with your doctor at home. Sharing detailed medical information ensures they are well-equipped to continue your care and understand the context of the therapy you underwent in Japan.
Remote Consultations: We offer the option of remote follow-up consultations via video call. This allows you to discuss your progress, ask questions, and receive guidance directly from our physicians in Osaka without needing to travel.
Dedicated Communication Channels: Our clinic maintains clear communication channels for international patients to reach out with any concerns or questions that may arise after they return home.

The Process: How We Coordinate with Your Doctor Back Home

Our coordination process is designed to be straightforward and effective. It begins before your treatment, where we discuss the importance of involving your primary care physician. After your therapy is complete, we prepare a detailed treatment summary. This document serves as a vital bridge between our clinic and your local medical team. You can share this report with your doctor, who can then use it to inform their follow-up care plan. If your physician has specific questions or requires further details, our team is available to communicate with them directly, ensuring all parties are aligned on your health management strategy. This collaborative framework promotes safety and continuity of care across borders.

What to Consider Before Traveling for Treatment

Planning for medical travel requires careful consideration. Before deciding on stem cell therapy in Japan, we encourage patients to take the following steps:

Consult Your Local Doctor: Discuss your interest in regenerative medicine with your primary physician. Their involvement from the beginning can make post-treatment coordination much smoother.
Understand the Treatment: Adipose-derived stem cell therapy uses mesenchymal stem cells collected from your own fat tissue. It is important to understand that this is offered as a private (non-insured) medical service, and individual responses and outcomes can vary.
Regulatory Framework in Japan: In Japan, regenerative medicine is provided under the Act on the Safety of Regenerative Medicine. Our treatments are administered in compliance with this law, based on a plan submitted to and accepted by the Ministry of Health, Labour and Welfare.
Discuss Details with a Physician: The suitability of this therapy, along with the potential risks, side effects, treatment duration, and associated costs, must be determined through a consultation with a physician. A doctor’s assessment is necessary to decide if you are an appropriate candidate.

Learn More About Adipose-Derived Stem Cell Therapy in Osaka

For those interested in the specifics of the adipose-derived stem cell therapy offered at our clinic, we invite you to review our detailed treatment page. It provides further information on the process, features, and frequently asked questions. The decision to proceed with any medical treatment should be made after careful consideration and a thorough discussion with a qualified physician. To find out if this therapy may be an option for you, please schedule a consultation with our medical team.

For more details, please visit our Adipose-Derived Stem Cell Therapy page.

Conclusion: A Commitment to Continuous Patient Care

At Grand Green Osaka Umekita Clinic, our commitment to patient care extends beyond your visit to Japan. We believe that providing robust follow-up support is an integral part of responsible medical practice, especially for our international patients. By fostering collaboration with your local healthcare providers and offering accessible communication, we strive to ensure you feel supported throughout your entire health journey. If you are considering regenerative medicine in Japan, we are here to answer your questions and discuss how we can support your post-treatment care.

Learn more about Adipose-Derived Stem Cell Therapy

References

Supervising Physician

Director, Medical Corporation Shimada Clinic
Head of Clinical Practice, Grand Green Osaka Umekita Clinic

Hidenori Shimada

Graduated from the University of Tokushima Faculty of Medicine in 2005. After his initial residency, he obtained U.S. medical certification (ECFMG) and trained as a sub-intern in general surgery at the University of Washington. After completing the doctoral program at Kyoto University Graduate School of Medicine and working as a researcher at the Center for iPS Cell Research and Application (CiRA), Kyoto University, he founded Shimada Clinic in 2013. At Grand Green Osaka Umekita Clinic (https://umekitaclinic.org), he is engaged in a wide range of care, from internal medicine and pediatrics to cell therapy and aesthetic medicine.

* The physician supervision of this article covers its academic content only and does not constitute a recommendation of any specific treatment or product.

Back to article list › Back to Adipose-Derived Stem Cell Therapy ›